Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for endotracheal intubation in neonates: a dose-finding trial
2022-501858-11-00Phase 3Authorised
- Sponsor
- Ghent University Hospital
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of remifentanil in Need for endotracheal intubation and respiratory failure, sponsored by Ghent University Hospital. Primary endpoints: Successful outcome of intubation with satisfactory sedation and Level of sedation. Planned start Jan 2023; status: authorised.
02
Drugs
remifentanil
03
Conditions
Need for endotracheal intubationrespiratory failure
Beyond the preview
Go deeper on 2022-501858-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501858-11-00.